Literature DB >> 19258516

Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer.

R Martin-Fardon1, M A S Baptista, C V Dayas, F Weiss.   

Abstract

To advance understanding of the potential of metabotropic glutamate receptor (mGluR) 5 as treatment targets for cocaine addiction, the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl) ethynyl]piperidine] (a selective mGluR5 antagonist) on conditioned reinstatement of cocaine seeking were examined. To test whether modification of conditioned reinstatement by MTEP is selective for drug-directed behavior or reflects general actions on motivated behavior, effects of MTEP on reinstatement induced by a stimulus conditioned to palatable conventional reward, sweetened condensed milk (SCM), were also evaluated. Previous data suggest that mGluR manipulations preferentially interfere with conditioned reinstatement compared with cocaine self-administration. Therefore, the effects of MTEP on cocaine self-administration were compared with MTEP's effects on SCM-reinforced behavior using the same cocaine doses and SCM concentrations employed for establishing conditioned reinstatement. Male Wistar rats were trained to associate a discriminative stimulus (S(D)) with response-contingent availability of cocaine or SCM and subjected to reinstatement tests after extinction of cocaine or SCM-reinforced behavior. MTEP (0.3-10 mg/kg i.p.) dose-dependently attenuated the response-reinstating effects of both the cocaine S(D) and SCM S(D). MTEP also decreased cocaine self-administration without a clear graded dose-response profile and did not modify SCM-reinforced responding. The findings implicate mGluR5-regulated glutamate transmission in appetitive behavior controlled by reward-related stimuli but without selectivity for cocaine seeking. However, the data suggest a differential role for mGluR5 in the acute reinforcing effects of cocaine versus conventional reward. These observations identify mGluR5 as potential treatment targets for cocaine relapse prevention, although the profile of action of mGluR5 antagonists remains to be more closely examined for potential anhedonic effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258516      PMCID: PMC2683783          DOI: 10.1124/jpet.109.151357

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  45 in total

1.  Hippocampal N-methyl-D-aspartate receptor-mediated encoding and retrieval processes in spatial working memory: delay-interposed radial maze performance in rats.

Authors:  T Yoshihara; Y Ichitani
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

Review 2.  Metabotropic glutamate receptors in brain function and pathology.

Authors:  D D Schoepp; P J Conn
Journal:  Trends Pharmacol Sci       Date:  1993-01       Impact factor: 14.819

Review 3.  Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy.

Authors:  N R Richardson; D C Roberts
Journal:  J Neurosci Methods       Date:  1996-05       Impact factor: 2.390

Review 4.  Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research.

Authors:  M J Kreek
Journal:  NIDA Res Monogr       Date:  1997

5.  (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus.

Authors:  A J Doherty; M J Palmer; J M Henley; G L Collingridge; D E Jane
Journal:  Neuropharmacology       Date:  1997-02       Impact factor: 5.250

Review 6.  Pharmacology and functions of metabotropic glutamate receptors.

Authors:  P J Conn; J P Pin
Journal:  Annu Rev Pharmacol Toxicol       Date:  1997       Impact factor: 13.820

7.  Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization.

Authors:  R C Pierce; K Bell; P Duffy; P W Kalivas
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

8.  Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats.

Authors:  D C Roberts
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior.

Authors:  Pia Bäckström; Daniel Bachteler; Sabrina Koch; Petri Hyytiä; Rainer Spanagel
Journal:  Neuropsychopharmacology       Date:  2004-05       Impact factor: 7.853

Review 10.  The ups and downs of addiction: role of metabotropic glutamate receptors.

Authors:  Paul J Kenny; Athina Markou
Journal:  Trends Pharmacol Sci       Date:  2004-05       Impact factor: 14.819

View more
  58 in total

1.  mGlu receptors and drug addiction.

Authors:  Richard M Cleva; M Foster Olive
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-20

2.  Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.

Authors:  Astrid K Stoker; Berend Olivier; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2011-12-03       Impact factor: 4.530

Review 3.  Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.

Authors:  M Foster Olive
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

4.  Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.

Authors:  Peter R Kufahl; M Foster Olive
Journal:  J Addict Res Ther       Date:  2011-11-15

5.  The effects of mGluR2/3 activation on acute and repeated amphetamine-induced locomotor activity in differentially reared male rats.

Authors:  David L Arndt; Jennifer C Arnold; Mary E Cain
Journal:  Exp Clin Psychopharmacol       Date:  2014-01-27       Impact factor: 3.157

6.  Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans.

Authors:  Thomas M Keck; Hong-Ju Yang; Guo-Hua Bi; Yong Huang; Hai-Ying Zhang; Ratika Srivastava; Eliot L Gardner; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Psychopharmacology (Berl)       Date:  2013-04-25       Impact factor: 4.530

7.  The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine.

Authors:  Valeria Tronci; Svetlana Vronskaya; Nicholas Montgomery; Daniela Mura; David J K Balfour
Journal:  Psychopharmacology (Berl)       Date:  2010-04-27       Impact factor: 4.530

8.  Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5).

Authors:  Christopher M Olsen; Daniel S Childs; Gregg D Stanwood; Danny G Winder
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  The role of ventral and dorsal striatum mGluR5 in relapse to cocaine-seeking and extinction learning.

Authors:  Lori A Knackstedt; Heather L Trantham-Davidson; Marek Schwendt
Journal:  Addict Biol       Date:  2013-05-27       Impact factor: 4.280

10.  Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.

Authors:  Brittney S Bates; Alice L Rodriguez; Andrew S Felts; Ryan D Morrison; Daryl F Venable; Anna L Blobaum; Frank W Byers; Kera P Lawson; J Scott Daniels; Colleen M Niswender; Carrie K Jones; P Jeffrey Conn; Craig W Lindsley; Kyle A Emmitte
Journal:  Bioorg Med Chem Lett       Date:  2014-06-11       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.